Preface by TLB Staff Writer: Christopher Wyatt
As most people know the last few years has seen significant outbreaks of mumps among American college students who have not had the illness. Many of these outbreaks have happened in the fully vaccinated. Such outbreaks are happening in the fully vaccinated due to the fact there are very few Americans under the age of 60 who have not been poisoned by the combined mumps, measles, rubella vaccine. It is also because the vaccine does not work! Merck has been involved in an ongoing lawsuit claiming that they falsified the effectiveness of the mumps vaccine.
Rather than removing this faulty vaccine from the market the pharmaceutical industry and the media have decided to push the idea that the vaccine somehow makes a mild illness milder and they play up potential side effects which in a properly cared for individual is non existent.
One of those mumps complications they like to play up is the idea of sterility, but upon further research you can find that this is an old wives tale. The late Dr Robert Mendelsohn, M.D. was quoted as saying:
“If total sterility as a consequence of orchitis were a significant threat, and if the mumps immunizations assured adult males that they would not contract it, I would be among those doctors who urge immunization. I’m not, because their argument makes no sense. Orchitis rarely causes sterility, and when it does, because only one testicle is usually affected, the sperm production capacity of the unaffected testicle could repopulate the world! And that’s not all. No one knows whether the mumps vaccination confers an immunity that lasts into the adult years. Consequently, there is an open question whether, when your child is immunized against mumps at fifteen months arid escapes this disease in childhood, he may suffer more serious consequences when he contracts it as an adult.”
Not only is it a myth that mumps causes sterility they have known for a very long time that mumps has health benefits. Mumps along with the other childhood illnesses have been shown to lower cancer rates. If this were not enough, a history of mumps has been shown to reduce the complications of atherosclerotic cardiovascular disease. There was an even stronger reduction of compilations if the personal also had a history of having the measles.
Knowing that mumps has real benefits should make people why they are pushing for a third dose of the MMR or are even giving the vaccine in the first place. Could it be that human arrogance, greed, and a need to control others is behind such tactics? Whatever the motives are it is clear that the childhood illnesses all have benefits and that vaccines cause immeasurable harm. Actively seek out the childhood illnesses, have them, and become immune! It is what parents did for many generations until big pharma and the CDC became involved! For those who want to know what mumps is really like take a look at the following blog post.
We The People NOT They The Elite! (CW)
Third Dose of Mumps Vaccine Could Help Stop Outbreaks, Researchers Say
By Helen Branswell
An extra dose of the combined measles, mumps, and rubella vaccine can help to stop mumps outbreaks, a new study suggests.
The research, published in the New England Journal of Medicine and based on analysis of data from a large mumps outbreak at the University of Iowa in 2015-2016, showed that getting a third dose of MMR vaccine cut the risk of contracting the mumps by 78 percent.
“The thing that this study particularly adds is that a third dose may have a role — at least in outbreak control — for mumps,” said Dr. Saad Omer, a professor of epidemiology and pediatrics at Emory University. Omer, whose work focuses on vaccinations, was not involved in the new study, which was published Wednesday.
Large and protracted mumps epidemics have been happening with increasing frequency in recent years among college students, sports teams, and communities of people who live in close proximity to one another — even though in many cases people who contract the virus have received both recommended doses of the MMR vaccine. The situation has left the public health officials who set U.S. vaccination policy puzzling over what is happening and how to respond.
The panel of experts that advises the Centers for Disease Control and Prevention on vaccinations, the Advisory Committee on Immunization Practices, has set up a working group to investigate the issue and to recommend changes to mumps vaccination policy, if the evidence supports changes. Those recommendations may be brought forward — and voted on — as early as next month, when the ACIP meets again.
The mumps virus, which is transmitted in saliva, causes an illness with many common symptoms — fever, headache, muscle aches. But the virus also infects salivary glands, leading to pronounced swelling on one or both sides of the face. In males infected after puberty, it can also induce swelling of the testicles, a painful condition known as orchitis.
Serious complications of mumps are rare, but can include encephalitis (inflammation of the brain), deafness, and infertility.
Before the mumps vaccine was introduced in the U.S. in 1967, there were upward of 186,000 cases of mumps a year. Annual case counts plummeted after 1977, when ACIP recommended all children receive a dose of MMR vaccine, and fell further still after a second dose was recommended after 1989.
More recently, 6,000 or 7,000 cases in a year is deemed a bad year for mumps. So far this year there have been at least 4,240 cases reported nationally.
In an outbreak at the University of Iowa, 98 percent of the roughly 20,000 students had received two doses of MMR vaccine. Still, 259 students contracted the virus during the outbreak.
In the new study, researchers — from the CDC and the local and state public health departments — went over the medical records of the infected students and saw a pattern. The longer it had been since the students received their second dose of MMR vaccine, the greater their risk of contracting mumps. In fact, students who had received their second shot 13 years — or more — before were nine times more likely to be infected than students who had been vaccinated more recently.
“Collectively these data suggest waning immunity from the second MMR vaccine dose,” said lead author Dr. Cristina Cardemil, a medical epidemiologist in CDC’s division of viral diseases.
One of the senior authors, Dr. Manisha Patel, said the mumps working group is considering these findings and other data as it deliberates on what recommendations to present to ACIP.
One thing that’s not on the table, Patel said, is proposing a delay to children’s second dose of MMR vaccine. The CDC recommends children get their first dose of the vaccine between 12 and 15 months of age and their second between the ages of 4 and 6.
“I will tell you the work group right now is not considering tweaking the one or two dose schedule or moving anything around,” Patel said.
Omer said the group could consider recommending that all teenagers get a third dose of MMR vaccine around the time they get ready to head to college. But he acknowledged the new study doesn’t provide the evidence needed to advocate for an across-the-board third dose recommendation.
Dr. Stanley Plotkin, who played a key role in the development of the rubella vaccine, said he believes a new mumps vaccine is needed. He suggested that a vaccine made with killed or inactivated mumps virus that could be given to teenagers as a booster shot could increase their level of protective antibodies. (The MMR vaccine is made with live but weakened viruses.)
“We can respond like firemen to these outbreaks or we can try to fix the problem prophylactically,” said Plotkin, who consults with pharmaceutical companies and was a consultant to the ACIP’s mumps working group.
Developing a whole new vaccine would cost hundreds of millions of dollars, and Plotkin admitted there’s little enthusiasm for his idea. But he insisted highly publicized mumps outbreaks in fully vaccinated individuals carry a cost as well.
“I’m concerned that the reputation of vaccination is going to suffer if we have these continued outbreaks,” Plotkin said.
Omer didn’t see that as a solution, saying there aren’t new mumps vaccines in the development pipeline, nor are there the financial incentives for industry to produce them.
Follow TLB on Twitter @thetlbproject